{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:41:53Z","timestamp":1782772913750,"version":"3.54.5"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National Key Research and Development Program of China","award":["2021YF2301500"],"award-info":[{"award-number":["2021YF2301500"]}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["YG2023ZD02"],"award-info":[{"award-number":["YG2023ZD02"]}]},{"name":"Shanghai Program for Outstanding Medical Academic Leader","award":["2022LJ016"],"award-info":[{"award-number":["2022LJ016"]}]},{"name":"Shanghai Municipal Optimization Program for Hospital Clinical Management","award":["SHDC22021207"],"award-info":[{"award-number":["SHDC22021207"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s00203-025-04460-7","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:11:48Z","timestamp":1757340708000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preparation and characterization of a Llama VHH-hFc chimeric antibody recognizing conserved neutralization epitope of H5N1 hemagglutinin with high affinity"],"prefix":"10.1007","volume":"207","author":[{"given":"Lingyan","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"4460_CR1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.canlet.2009.08.003","volume":"289","author":"A Bell","year":"2010","unstructured":"Bell A, Wang ZJ, Arbabi-Ghahroudi M et al (2010) Differential tumor-targeting abilities of three single-domain antibody formats. Cancer Lett 289:81\u201390","journal-title":"Cancer Lett"},{"key":"4460_CR2","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1080\/21645515.2017.1363135","volume":"14","author":"CM Berry","year":"2018","unstructured":"Berry CM (2018) Antibody immunoprophylaxis and immunotherapy for influenza virus infection: utilization of monoclonal or polyclonal antibodies? Hum Vaccin Immunother 14:796\u2013799","journal-title":"Hum Vaccin Immunother"},{"key":"4460_CR3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1161\/CIRCRESAHA.112.265140","volume":"110","author":"A Broisat","year":"2012","unstructured":"Broisat A, Hernot S, Toczek J et al (2012) Nanobodies targeting mouse\/human VCAM1 for the nuclear imaging of atherosclerotic lesions. Circ Res 110:927\u2013937","journal-title":"Circ Res"},{"key":"4460_CR4","doi-asserted-by":"crossref","first-page":"e38126","DOI":"10.1371\/journal.pone.0038126","volume":"7","author":"Z Cao","year":"2012","unstructured":"Cao Z, Meng J, Li X et al (2012) The epitope and neutralization mechanism of AVFluIgG01, a broad-reactive human monoclonal antibody against H5N1 influenza virus. PLoS ONE 7:e38126","journal-title":"PLoS ONE"},{"key":"4460_CR5","doi-asserted-by":"crossref","first-page":"8278","DOI":"10.1128\/JVI.03178-13","volume":"88","author":"FM Cardoso","year":"2014","unstructured":"Cardoso FM, Ibanez LI, Van den Hoecke S et al (2014) Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge. J Virol 88:8278\u20138296","journal-title":"J Virol"},{"key":"4460_CR6","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.smim.2004.08.003","volume":"16","author":"MM Davis","year":"2004","unstructured":"Davis MM (2004) The evolutionary and structural \u2018logic\u2019 of antigen receptor diversity. Semin Immunol 16:239\u2013243","journal-title":"Semin Immunol"},{"key":"4460_CR7","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1111\/pbi.12094","volume":"11","author":"S De Buck","year":"2013","unstructured":"De Buck S, Nolf J, De Meyer T et al (2013) Fusion of an Fc chain to a VHH boosts the accumulation levels in Arabidopsis seeds. Plant Biotechnol J 11:1006\u20131016","journal-title":"Plant Biotechnol J"},{"key":"4460_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.dci.2005.06.010","volume":"30","author":"E De Genst","year":"2006","unstructured":"De Genst E, Saerens D, Muyldermans S, Conrath K (2006) Antibody repertoire development in camelids. Dev Comp Immunol 30:187\u2013198","journal-title":"Dev Comp Immunol"},{"key":"4460_CR9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11103-013-0118-0","volume":"84","author":"T De Meyer","year":"2014","unstructured":"De Meyer T, Eeckhout D, De Rycke R et al (2014) Generation of VHH antibodies against the Arabidopsis Thaliana seed storage proteins. Plant Mol Biol 84:83\u201393","journal-title":"Plant Mol Biol"},{"key":"4460_CR10","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1467-7652.2009.00494.x","volume":"8","author":"B De Muynck","year":"2010","unstructured":"De Muynck B, Navarre C, Boutry M (2010) Production of antibodies in plants: status after Twenty years. Plant Biotechnol J 8:529\u2013563","journal-title":"Plant Biotechnol J"},{"key":"4460_CR11","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.virol.2009.07.018","volume":"393","author":"L Du","year":"2009","unstructured":"Du L, Zhao G, Chan CC et al (2009) Recombinant receptor-binding domain of SARS-CoV Spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity. Virology 393:144\u2013150","journal-title":"Virology"},{"key":"4460_CR12","doi-asserted-by":"crossref","first-page":"e95263","DOI":"10.1371\/journal.pone.0095263","volume":"9","author":"A Fatima","year":"2014","unstructured":"Fatima A, Wang H, Kang K et al (2014) Development of VHH antibodies against dengue virus type 2 NS1 and comparison with monoclonal antibodies for use in immunological diagnosis. PLoS ONE 9:e95263","journal-title":"PLoS ONE"},{"key":"4460_CR13","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1128\/JVI.79.5.2814-2822.2005","volume":"79","author":"RA Fouchier","year":"2005","unstructured":"Fouchier RA, Munster V, Wallensten A et al (2005) Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79:2814\u20132822","journal-title":"J Virol"},{"key":"4460_CR14","doi-asserted-by":"crossref","first-page":"105893","DOI":"10.1016\/j.antiviral.2024.105893","volume":"226","author":"AJ Gehring","year":"2024","unstructured":"Gehring AJ, Salimzadeh L (2024) Current and future use of antibody-based passive immunity to prevent or control HBV\/HDV infections. Antiviral Res 226:105893","journal-title":"Antiviral Res"},{"key":"4460_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/363446a0","volume":"363","author":"C Hamers-Casterman","year":"1993","unstructured":"Hamers-Casterman C, Atarhouch T, Muyldermans S et al (1993) Naturally occurring antibodies devoid of light chains. Nature 363:446\u2013448","journal-title":"Nature"},{"key":"4460_CR16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.vetmic.2006.10.029","volume":"120","author":"MM Harmsen","year":"2007","unstructured":"Harmsen MM, van Solt CB, Fijten HP et al (2007) Passive immunization of Guinea pigs with Llama single-domain antibody fragments against foot-and-mouth disease. Vet Microbiol 120:193\u2013206","journal-title":"Vet Microbiol"},{"key":"4460_CR17","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1016\/j.molimm.2008.04.011","volume":"45","author":"I Hmila","year":"2008","unstructured":"Hmila I, Abdallah RB, Saerens D et al (2008) VHH, bivalent domains and chimeric heavy chain-only antibodies with high neutralizing efficacy for Scorpion toxin aahi\u2019. Mol Immunol 45:3847\u20133856","journal-title":"Mol Immunol"},{"key":"4460_CR18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1128\/CVI.00465-08","volume":"16","author":"HT Ho","year":"2009","unstructured":"Ho HT, Qian HL, He F et al (2009) Rapid detection of H5N1 subtype influenza viruses by antigen capture enzyme-linked immunosorbent assay using H5- and N1-specific monoclonal antibodies. Clin Vaccine Immunol 16:726\u2013732","journal-title":"Clin Vaccine Immunol"},{"key":"4460_CR19","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1186\/1471-2105-9-538","volume":"9","author":"YX Huang","year":"2008","unstructured":"Huang YX, Bao YL, Guo SY et al (2008) Pep-3D-Search: a method for B-cell epitope prediction based on Mimotope analysis. BMC Bioinformatics 9:538","journal-title":"BMC Bioinformatics"},{"key":"4460_CR20","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3390\/pathogens9110917","volume":"9","author":"J Hussen","year":"2020","unstructured":"Hussen J, Kandeel M, Hemida MG, Al-Mubarak AIA (2020) Antibody-Based immunotherapeutic strategies for COVID-19. Pathogens 9:917","journal-title":"Pathogens"},{"key":"4460_CR21","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/infdis\/jiq168","volume":"203","author":"LI Ibanez","year":"2011","unstructured":"Ibanez LI, De Filette M, Hultberg A et al (2011) Nanobodies with in vitro neutralizing activity protect mice against H5N1 influenza virus infection. J Infect Dis 203:1063\u20131072","journal-title":"J Infect Dis"},{"key":"4460_CR22","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1042\/BA20060071","volume":"47","author":"A Ismaili","year":"2007","unstructured":"Ismaili A, Jalali-Javaran M, Rasaee MJ et al (2007) Production and characterization of anti-(mucin MUC1) single-domain antibody in tobacco (Nicotiana tabacum cultivar Xanthi). Biotechnol Appl Biochem 47:11\u201319","journal-title":"Biotechnol Appl Biochem"},{"key":"4460_CR23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-61779-931-0_15","volume":"901","author":"S Jevsevar","year":"2012","unstructured":"Jevsevar S, Kusterle M, Kenig M (2012) PEGylation of antibody fragments for half-life extension. Methods Mol Biol 901:233\u2013246","journal-title":"Methods Mol Biol"},{"key":"4460_CR24","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.3390\/ijms24065994","volume":"24","author":"BK Jin","year":"2023","unstructured":"Jin BK, Odongo S, Radwanska M, Magez S (2023) NANOBODIES(R): A review of diagnostic and therapeutic applications. Int J Mol Sci 24:5994","journal-title":"Int J Mol Sci"},{"key":"4460_CR25","doi-asserted-by":"crossref","first-page":"8390","DOI":"10.1038\/s41598-017-08273-7","volume":"7","author":"K Koch","year":"2017","unstructured":"Koch K, Kalusche S, Torres JL et al (2017) Selection of nanobodies with broad neutralizing potential against primary HIV-1 strains using soluble subtype C gp140 envelope trimers. Sci Rep 7:8390","journal-title":"Sci Rep"},{"key":"4460_CR26","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1021\/ac058044j","volume":"78","author":"RC Ladenson","year":"2006","unstructured":"Ladenson RC, Crimmins DL, Landt Y, Ladenson JH (2006) Isolation and characterization of a thermally stable Recombinant anti-caffeine heavy-chain antibody fragment. Anal Chem 78:4501\u20134508","journal-title":"Anal Chem"},{"key":"4460_CR27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s10096-020-03840-9","volume":"39","author":"T Lampejo","year":"2020","unstructured":"Lampejo T (2020) Influenza and antiviral resistance: an overview. Eur J Clin Microbiol Infect Dis 39:1201\u20131208","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4460_CR28","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","volume":"145","author":"TC Luke","year":"2006","unstructured":"Luke TC, Kilbane EM, Jackson JL, Hoffman SL (2006) Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Ann Intern Med 145:599\u2013609","journal-title":"Ann Intern Med"},{"key":"4460_CR29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jim.2007.04.008","volume":"324","author":"DR Maass","year":"2007","unstructured":"Maass DR, Sepulveda J, Pernthaner A, Shoemaker CB (2007) Alpaca (Lama pacos) as a convenient source of Recombinant Camelid heavy chain antibodies (VHHs). J Immunol Methods 324:13\u201325","journal-title":"J Immunol Methods"},{"key":"4460_CR30","doi-asserted-by":"crossref","first-page":"e0162351","DOI":"10.1371\/journal.pone.0162351","volume":"11","author":"L Maffey","year":"2016","unstructured":"Maffey L, Vega CG, Mino S, Garaicoechea L, Parreno V (2016) Anti-VP6 VHH: an experimental treatment for rotavirus A-Associated disease. PLoS ONE 11:e0162351","journal-title":"PLoS ONE"},{"key":"4460_CR31","doi-asserted-by":"crossref","first-page":"105807","DOI":"10.1016\/j.antiviral.2024.105807","volume":"222","author":"A Matthys","year":"2024","unstructured":"Matthys A, Saelens X (2024) Promises and challenges of single-domain antibodies to control influenza. Antiviral Res 222:105807","journal-title":"Antiviral Res"},{"key":"4460_CR32","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.3390\/vaccines12091044","volume":"12","author":"Y Medina-Armenteros","year":"2024","unstructured":"Medina-Armenteros Y, Cajado-Carvalho D, das Neves Oliveira R, Apetito Akamatsu M, Lee Ho P (2024) Recent occurrence, diversity, and candidate vaccine virus selection for pandemic H5N1: alert is in the air. Vaccines (Basel) 12:1044","journal-title":"Vaccines (Basel)"},{"key":"4460_CR33","doi-asserted-by":"crossref","first-page":"e29926","DOI":"10.1002\/jmv.29926","volume":"96","author":"N Mukerjee","year":"2024","unstructured":"Mukerjee N, Maitra S, Mukherjee D et al (2024) Harnessing protacs to combat H5N1 influenza: A new frontier in viral destruction. J Med Virol 96:e29926","journal-title":"J Med Virol"},{"key":"4460_CR34","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.nucmedbio.2015.03.003","volume":"42","author":"M Rotman","year":"2015","unstructured":"Rotman M, Welling MM, van den Boogaard ML et al (2015) Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP\/PS1 mice but does not increase brain uptake. Nucl Med Biol 42:695\u2013702","journal-title":"Nucl Med Biol"},{"key":"4460_CR35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/hep.22609","volume":"49","author":"B Serruys","year":"2009","unstructured":"Serruys B, Van Houtte F, Verbrugghe P, Leroux-Roels G, Vanlandschoot P (2009) Llama-derived single-domain intrabodies inhibit secretion of hepatitis B virions in mice. Hepatology 49:39\u201349","journal-title":"Hepatology"},{"key":"4460_CR36","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1146\/annurev.biochem.69.1.531","volume":"69","author":"JJ Skehel","year":"2000","unstructured":"Skehel JJ, Wiley DC (2000) Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69:531\u2013569","journal-title":"Annu Rev Biochem"},{"key":"4460_CR37","doi-asserted-by":"crossref","first-page":"16936","DOI":"10.1073\/pnas.0608157103","volume":"103","author":"GJ Smith","year":"2006","unstructured":"Smith GJ, Fan XH, Wang J et al (2006) Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A 103:16936\u201316941","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4460_CR38","doi-asserted-by":"crossref","first-page":"e5476","DOI":"10.1371\/journal.pone.0005476","volume":"4","author":"L Sun","year":"2009","unstructured":"Sun L, Lu X, Li C et al (2009) Generation, characterization and epitope mapping of two neutralizing and protective human Recombinant antibodies against influenza A H5N1 viruses. PLoS ONE 4:e5476","journal-title":"PLoS ONE"},{"key":"4460_CR39","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1080\/14712598.2023.2231344","volume":"23","author":"Y Tanaka","year":"2023","unstructured":"Tanaka Y (2023) Ozoralizumab: first Nanobody(R) therapeutic for rheumatoid arthritis. Expert Opin Biol Ther 23:579\u2013587","journal-title":"Expert Opin Biol Ther"},{"key":"4460_CR40","doi-asserted-by":"crossref","first-page":"e0004902","DOI":"10.1371\/journal.pntd.0004902","volume":"10","author":"S Terryn","year":"2016","unstructured":"Terryn S, Francart A, Rommelaere H, Stortelers C, Van Gucht S (2016) Post-exposure treatment with Anti-rabies VHH and vaccine significantly improves protection of mice from lethal rabies infection. PLoS Negl Trop Dis 10:e0004902","journal-title":"PLoS Negl Trop Dis"},{"key":"4460_CR41","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.molimm.2013.07.010","volume":"56","author":"T Velkov","year":"2013","unstructured":"Velkov T, Ong C, Baker MA et al (2013) The antigenic architecture of the hemagglutinin of influenza H5N1 viruses. Mol Immunol 56:705\u2013719","journal-title":"Mol Immunol"},{"key":"4460_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ymeth.2013.07.018","volume":"65","author":"T Vink","year":"2014","unstructured":"Vink T, Oudshoorn-Dickmann M, Roza M, Reitsma JJ, de Jong RN (2014) A simple, robust and highly efficient transient expression system for producing antibodies. Methods 65:5\u201310","journal-title":"Methods"},{"key":"4460_CR43","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.chom.2025.01.010","volume":"33","author":"L Wang","year":"2025","unstructured":"Wang L, Gao GF (2025) A brief history of human infections with H5Ny avian influenza viruses. Cell Host Microbe 33:176\u2013181","journal-title":"Cell Host Microbe"},{"key":"4460_CR44","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.bbrc.2009.03.119","volume":"382","author":"SF Wang","year":"2009","unstructured":"Wang SF, Chen KH, Thitithanyanont A et al (2009) Generating and characterizing monoclonal and polyclonal antibodies against avian H5N1 hemagglutinin protein. Biochem Biophys Res Commun 382:691\u2013696","journal-title":"Biochem Biophys Res Commun"},{"key":"4460_CR45","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1093\/infdis\/jiae379","volume":"230","author":"RJ Webby","year":"2024","unstructured":"Webby RJ, Uyeki TM (2024) An update on highly pathogenic avian influenza A(H5N1) virus, clade 2.3.4.4b. J Infect Dis 230:533\u2013542","journal-title":"J Infect Dis"},{"key":"4460_CR46","doi-asserted-by":"crossref","first-page":"e28309","DOI":"10.1371\/journal.pone.0028309","volume":"6","author":"G Wei","year":"2011","unstructured":"Wei G, Meng W, Guo H et al (2011) Potent neutralization of influenza A virus by a single-domain antibody blocking M2 ion channel protein. PLoS ONE 6:e28309","journal-title":"PLoS ONE"},{"key":"4460_CR47","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1042\/BA20080076","volume":"53","author":"S Winichayakul","year":"2009","unstructured":"Winichayakul S, Pernthaner A, Scott R, Vlaming R, Roberts N (2009) Head-to-tail fusions of Camelid antibodies can be expressed in planta and bind in rumen fluid. Biotechnol Appl Biochem 53:111\u2013122","journal-title":"Biotechnol Appl Biochem"},{"key":"4460_CR48","doi-asserted-by":"crossref","first-page":"a038778","DOI":"10.1101\/cshperspect.a038778","volume":"10","author":"NC Wu","year":"2020","unstructured":"Wu NC, Wilson IA (2020) Influenza hemagglutinin structures and antibody recognition. Cold Spring Harb Perspect Med 10:a038778","journal-title":"Cold Spring Harb Perspect Med"},{"key":"4460_CR49","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.antiviral.2014.03.005","volume":"106","author":"R Wu","year":"2014","unstructured":"Wu R, Li X, Leung HC et al (2014) A novel neutralizing antibody against diverse clades of H5N1 influenza virus and its mutants capable of airborne transmission. Antiviral Res 106:13\u201323","journal-title":"Antiviral Res"},{"key":"4460_CR50","doi-asserted-by":"crossref","first-page":"e88777","DOI":"10.1371\/journal.pone.0088777","volume":"9","author":"F Xiong","year":"2014","unstructured":"Xiong F, Xia L, Wang J et al (2014) A high-affinity CDR-grafted antibody against influenza A H5N1 viruses recognizes a conserved epitope of H5 hemagglutinin. PLoS ONE 9:e88777","journal-title":"PLoS ONE"},{"key":"4460_CR51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pep.2008.10.011","volume":"65","author":"J Zhang","year":"2009","unstructured":"Zhang J, Liu X, Bell A et al (2009) Transient expression and purification of chimeric heavy chain antibodies. Protein Expr Purif 65:77\u201382","journal-title":"Protein Expr Purif"},{"key":"4460_CR52","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357:1450\u20131451","journal-title":"N Engl J Med"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04460-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04460-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T13:14:10Z","timestamp":1758719650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04460-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["4460"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04460-7","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"13 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"252"}}